AKRO(Delisted)
Akero Therapeutics·NASDAQ
--
--(--)
Akero Therapeutics (AKRO) Financial Statements
Akero Therapeutics (AKRO) Cash Flow Statement
During Q3 2025, Akero Therapeutics (AKRO) generated -67.17M in cash flow from operating activities, 56.78M from investing activities, and -34.03M from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2018 | Q1,2019 | Q1,2020 | Q1,2021 | Q1,2022 | Q1,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Jan 1, 2018 | Jan 1, 2019 | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -338.00K -- | -5.44M -1510.65% | -11.32M -107.88% | -18.35M -62.11% | -22.88M -24.69% | -24.63M -7.68% | -48.63M -- | -35.14M -42.66% | -57.45M -- | -70.42M -- | -67.09M -37.97% | -67.66M -92.56% | -48.25M +16.03% | -67.17M +4.62% | -250.17M -- |
Net Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -55.19M -- | -53.34M -- | -55.99M -- | -72.70M -- | -70.02M -26.89% | -70.72M -32.58% | -70.50M -25.93% | -81.57M -12.19% | -292.82M -- |
Depreciation and Amortization | -- -- | -- -- | -103.00K -- | 132.00K +228.16% | 11.00K -91.67% | 111.00K +909.09% | 2.00K -- | 1.00K -99.10% | 1.00K -- | 1.00K -- | 15.00K +650.00% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 15.00K -- |
Stock-based Compensation | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 6.12M -- | 7.40M -- | 7.66M -- | 7.47M -- | 7.18M +17.33% | 8.78M +18.73% | 9.05M +18.27% | 9.26M +24.01% | 34.28M -- |
Impairment of Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- |
Change in Working Capital | 83.00K -- | -297.00K -457.83% | -565.00K -90.24% | -5.75M -918.23% | -299.00K +94.80% | -3.04M -918.06% | 3.93M -- | 13.07M +529.53% | -6.88M -- | -1.80M -- | -1.39M -135.36% | -3.61M -127.58% | 15.68M +327.77% | 6.18M +442.79% | 16.87M -- |
Change in Accounts Payable | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -4.23M -- | 6.46M -- | 1.09M -- | 10.57M -- | -16.11M -280.94% | 1.81M -71.95% | 2.39M +118.85% | 7.18M -32.10% | -4.73M -- |
Change in Other Working Capital | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 8.16M -- | 6.62M -- | -7.98M -- | -12.37M -- | 14.72M +80.47% | -5.42M -181.84% | 13.29M +266.58% | -992.00K +91.98% | 21.60M -- |
Other Non-cash Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -3.49M -- | -2.27M -- | -2.24M -- | -3.38M -- | -2.87M +17.75% | -2.12M +6.74% | -2.48M -10.59% | -1.05M +68.97% | -8.51M -- |
Net Cash Flows from Investing Activities | -- -- | -- -- | -6.28M -- | 19.00M +402.50% | 22.75M +19.74% | 17.59M -22.68% | 12.79M -- | 57.85M +228.87% | -255.90M -- | 73.07M -- | 15.27M +19.44% | -482.18M -933.52% | 79.34M +131.00% | 56.78M -22.29% | -330.79M -- |
Change in Investments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 12.79M -- | 57.85M -- | -254.90M -- | 73.07M -- | 15.27M +19.44% | -482.18M -933.52% | 79.34M +131.13% | 56.78M -22.29% | -330.79M -- |
Decrease in Investments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 71.00M -- | 96.83M -- | 84.51M -- | 131.00M -- | 95.00M +33.80% | 101.12M +4.43% | 155.02M +83.43% | 130.28M -0.55% | 481.41M -- |
Increase in Investments | -- -- | -- -- | 24.78M -- | -- -- | -- -- | 24.91M -- | 58.21M -- | 38.98M +56.47% | 339.41M -- | 57.93M -- | 79.73M +36.96% | 583.30M +1396.56% | 75.68M -77.70% | 73.50M +26.86% | 812.20M -- |
Change in long-term Equity Investments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -999.00K -- | 0 -- | 999.00K -- | -- -- | 0 +100.00% | 0 -- | -- -- |
Change in Subsidiaries | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -999.00K -- | 0 -- | 999.00K -- | -- -- | 0 +100.00% | 0 -- | -- -- |
Other Investing Activities | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -999.00K -- | -- -- | -- -- | -- -- | -- -- |
Net Cash Flows from Financing Activities | -- -- | -720.00K -- | 164.00K +122.78% | 24.00K -85.37% | 132.00K +450.00% | 15.15M +11379.55% | 502.00K -- | 366.94M +2321.55% | -150.00K -- | 3.07M -- | 75.99M +15037.65% | 395.53M +7.79% | 3.43M +2388.67% | -34.03M -1209.46% | 440.93M -- |
Change in Debt | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 10.00M -- | 0 -- | 0 -- | 0 -- | 0 -100.00% | 0 -- | -37.40M -- | -37.40M -- |
Issuance of long-term Debt | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 10.00M -- | 0 -- | -10.00M -- | 10.00M -- | 0 -100.00% | 0 -- | 0 +100.00% | 10.00M -- |
Change in Capital Stock | -- -- | -- -- | -- -- | 24.00K -- | 147.00K +512.50% | 456.00K +210.20% | 533.00K -- | 357.21M +78235.96% | 327.00K -- | 3.13M -- | 76.02M +14162.66% | 396.11M +10.89% | 3.43M +949.85% | 3.37M +7.67% | 478.93M -- |
Increase in Capital Stock | -- -- | -- -- | -- -- | 24.00K -- | 147.00K +512.50% | 456.00K +210.20% | 533.00K -- | 357.21M +78235.96% | 327.00K -- | 3.13M -- | 76.02M +14162.66% | 396.11M +10.89% | 3.43M +949.85% | 3.37M +7.67% | 478.93M -- |
Other Financing Activities | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -31.00K -- | -274.00K -- | -477.00K -- | -64.00K -- | -29.00K +6.45% | -576.00K -110.22% | 0 +100.00% | 0 +100.00% | -605.00K -- |
Net Increase in Cash and Cash Equivalents | -338.00K -- | -6.16M -1723.67% | -17.43M -182.84% | 678.00K +103.89% | 6.00K -99.12% | 8.11M +135083.33% | -35.34M -- | 389.65M +4703.93% | -313.50M -- | 5.71M -- | 24.17M +168.40% | -154.32M -139.60% | 34.53M +111.01% | -44.42M -877.88% | -140.03M -- |
Cash and Cash Equivalents at Beginning of Period | 618.00K -- | 76.00M +12197.73% | 64.85M -14.67% | 187.39M +188.97% | 150.59M -19.64% | 249.88M +65.93% | 269.55M -- | 234.21M -6.27% | 623.85M -- | 310.36M -- | 316.06M +17.26% | 340.24M +45.27% | 185.92M -70.20% | 220.45M -28.97% | 1.06B -- |
Cash and Cash Equivalents at End of Period | 280.00K -- | 69.84M +24841.43% | 47.41M -32.11% | 188.07M +296.65% | 150.60M -19.92% | 257.99M +71.31% | 234.21M -- | 623.85M +141.81% | 310.36M -- | 316.06M -- | 340.24M +45.27% | 185.92M -70.20% | 220.45M -28.97% | 176.03M -44.31% | 922.64M -- |
You can ask Aime
No Data
